Cinitapride Treatment for Functional Dyspepsia and GERD

First-line Treatment Options

The American Gastroenterological Association recommends lifestyle modifications, including regular aerobic exercise, as a first-line treatment for functional dyspepsia 1, 2
For patients with H. pylori infection, the American Gastroenterological Association suggests eradication therapy as a first-line treatment option 1, 2
The American Gastroenterological Association recommends acid suppression therapy, including proton pump inhibitors (PPIs) and histamine-2 receptor antagonists, as a first-line treatment for functional dyspepsia, particularly for epigastric pain (ulcer-like dyspepsia) 1, 2, 3
Prokinetics, including cinitapride, are recommended for patients with dysmotility-like symptoms, such as fullness, bloating, and early satiety 1, 2

The American Gastroenterological Association suggests tricyclic antidepressants (TCAs) as a second-line treatment option for functional dyspepsia, starting at low doses (e.g., amitriptyline 10 mg once daily) 1, 2
Antipsychotics, such as sulpiride and levosulpiride, may be considered as a second-line treatment option for functional dyspepsia 1, 2

The American College of Chest Physicians recommends prokinetic agents like cinitapride as an effective treatment for GERD management, particularly when combined with acid suppression therapy 4

The American Gastroenterological Association notes that cinitapride has a favorable safety profile, with minimal side effects, and does not appear to cause significant QT interval prolongation 5
However, the American Gastroenterological Association recommends avoiding the use of cinitapride with other medications that may prolong QT interval as a precautionary measure 5